Company Search:
Advanced Search
Sponsored Links
BioTime, Inc. Company Snapshot
BioTime, Inc. operates in the Biological products exc. diagnostic sector. In addition to historical fundamental analyses, the complete report available to purchase compares BioTime with three other companies in this sector in the United States: Fate Therapeutics Inc (2016 sales of $4.40 million of which 100% was Biopharmaceuticals), Asterias Biotherapeutics Inc ($6.95 million of which 100% was Regenerative Medicine), and Editas Medicine Inc ($6.05 million of which 100% was Pharmaceutical).

Sales Analysis. BioTime reported sales of $5.92 million for the year ending December of 2016. This represents a decrease of 15.8% versus 2015, when the company's sales were $7.04 million.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
BioTime, Inc.
  Stock Performance Chart for BioTime, Inc.
  Stock Data: Recent Stock Performance:
  Current Price (4/21/2017): 3.13
(Figures in U.S. Dollars)
1 Week -4.0%   13 Weeks -1.9%  
4 Weeks -5.7%   52 Weeks -0.6%  
BioTime, Inc. Key Data:
  Ticker: BTX Country: United States
  Exchanges: ASE Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Biological Products Exc. Diagnostic
  2016 Sales 5,923,000
(Year Ending Jan 2017).
Employees: 102
  Currency: U.S. Dollars Market Cap: 346,972,250
  Fiscal Yr Ends: December Shares Outstanding: 110,853,754
  Share Type: Common Closely Held Shares: 15,118,432
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.